ArticleClinical and experimental immunology2003

The bi-specific CD3 x NCAM antibody: a model to preactivate T cells prior to tumour cell lysis.

M Jensen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.